GlaxoSmithKline Consumer Healthcare Q3 PAT up by 19.73%

Company announces an interim dividend at 100%

 Gurgaon, October 26, 2006: GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the quarter ended September 30, 2006 . For this quarter, sales stood at Rs.329.1 crores, representing growth of 13.2%. PAT rose 19.7% to Rs. 36.2crores and PBT grew 17.7% to Rs.54.8 crores.  

The increase in PAT is driven by continuing strong sales performance of Horlicks, Boost and other products. Q3 saw Horlicks sales value growing at double digits driven by new advertising, first-in-India packaging innovation and effective consumer promotions.

 The company declared an interim dividend of Rs.10 per share which is 25% over last year.  

 "The Company's Q3 results are encouraging and what particularly pleases me is the fact that this growth has been led by our flagship brand Horlicks. This quarter has also been a period when independent industry bodies have recognised and rewarded innovation and excellence in marketing on our brands," said Nick Massey, Managing Director: GlaxoSmithKline Consumer Healthcare Ltd. "While unprecedented rise in input costs continue to be an area of concern, the Company has registered a healthy profit to sales ratio of 16.6% in this quarter, due to a well managed cost containment programme."          

For the nine months ended September 30, 2006 , sales stood at Rs.925.4 crores, 12.8% over last year. For the same period, PBT amounted to Rs.157.7 crores, representing a growth of 23.1% while PAT stood at Rs. 101.6 Crores; a growth of 18.5 % over 2005 levels.

_________________________________________________________________________

About GlaxoSmithKline Consumer Healthcare Ltd.

 GSKCH is an associate of GlaxoSmithKline plc. of the U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is one of the largest players in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 2700 people.

 GSKCH has a strong marketing and distribution network in India comprising over 1800 wholesalers and direct coverage of over 4,50,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent household names such as Eno, Crocin and Iodex.

For more information, please contact:

Shiraj Chakraborty

Head of Communications, GlaxoSmithKline Consumer Healthcare

Tel: 91-124-4097221

Email: shiraj.4.chakraborty@gsk.com